Results 121 to 130 of about 3,752 (164)

Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review. [PDF]

Medicine (Baltimore)
Jezani SN, Bastion MC.
europepmc   +1 more source

Preferential Locations of Polypoidal Lesions and Adjacent Pigment Epithelium Detachments in Polypoidal Choroidal Vasculopathy in a Japanese Population. [PDF]

Invest Ophthalmol Vis Sci
Kogo T, Muraoka Y, Hata M, Ishikura M, Nishigori N, Akiyama Y, Ueda-Arakawa N, Miyata M, Ooto S, Takahashi A, Miyake M, Tsujikawa A.   +11 more
europepmc   +1 more source

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment. [PDF]

Front Med (Lausanne)
Chen L, Wang C, Zhang W, Meng L, Sun L, Chen Y.   +5 more
europepmc   +1 more source

Correlation between complete polypoidal regression and visual outcomes in polypoidal choroidal vasculopathy eyes receiving intravitreal aflibercept. [PDF]

Eye (Lond)
Chaikitmongkol V, Chatromyen P, Choovuthayakorn J, Patikulsila D, Ruamviboonsuk P, Jirarattanasopa P, Watanachai N, Kunavisarut P, Ratanasukon M, Bhurayanontachai P, Bressler NM.   +10 more
europepmc   +1 more source

Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis. [PDF]

Ophthalmol Sci
Cheung CMG, Jackson TL, Wykoff CC, Khanani AM, Leitch IM, Baldwin ME, Slakter J.   +6 more
europepmc   +1 more source

Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials. [PDF]

BMC Ophthalmol
Quiroz-Reyes MA, Quiroz-Gonzalez EA, Quiroz-Gonzalez MA, Lima-Gomez V.   +3 more
europepmc   +1 more source

Polypoidal Choroidal Vasculopathy Complicated by Red Blood Cell-Coated Intraocular Lens: A Case Report. [PDF]

Cureus
Sawazono A, Funatsu R, Terasaki H, Mihara N, Sakamoto T.   +4 more
europepmc   +1 more source

Clinical characteristics and long-term treatment outcomes of polypoidal choroidal vasculopathy with classic type leakage. [PDF]

Sci Rep
Kim JH, Park SM, Kim JW, Kim CG.
europepmc   +1 more source

Unexpected retinal fluid compartment responses with anti-VEGF therapy in polypoidal choroidal vasculopathy: a case report of four patients. [PDF]

Front Ophthalmol (Lausanne)
Gilead N, Chong YJ, Ibrahim FNI, Sun C, Teo KYC, Cheung CMG.   +5 more
europepmc   +1 more source